ezyVet
2021
Outcome
Positioned IDEXX as the leader in cloud veterinary software, integrating clinical diagnostics directly into hospital practice workflows.
IDEXX Laboratories
Acquisitions
IDEXX Laboratories Acquisitions
3
Major Deals Covered
What are IDEXX Laboratories's biggest acquisitions?
This page covers 3 major deals from 2002 to 2021, each with its price where disclosed and the reason behind it.
- Major deals covered
- 3
- First deal
- 2002
- Most recent
- 2021
| Company | Year | Price | Purpose |
|---|---|---|---|
| ezyVet | 2021 | Undisclosed | Acquired innovative cloud-native veterinary practice management software provider based in New Zealand. |
| VetSolutions / Cornerstone Software | 2002 | Undisclosed | Acquired leading veterinary practice management software provider to establish software integration with diagnostic instruments. |
| Marshfield Laboratories Veterinary Division | 2019 | Undisclosed | Acquired veterinary diagnostic reference laboratory business to expand reference lab presence across the US Midwest. |
- What companies has IDEXX Laboratories bought?
- Major acquisitions by IDEXX Laboratories documented here include ezyVet (2021), Marshfield Laboratories Veterinary Division (2019) and VetSolutions / Cornerstone Software (2002).
- What is IDEXX Laboratories's most recent acquisition?
- The most recent IDEXX Laboratories acquisition documented here is ezyVet, in 2021.
Marshfield Laboratories Veterinary Division
2019
Outcome
Expanded reference lab courier logistics network and pathology capacity across core regional veterinary clusters.
VetSolutions / Cornerstone Software
2002
Outcome
Created the cornerstone of IDEXX's software division, embedding IDEXX diagnostic ordering directly into veterinary workflows.
IDEXX Laboratories's Growth & Acquisition Strategy
IDEXX's forward growth strategy centers on three secular expansion drivers: expanding international in-clinic analyzer placements, driving veterinary practice software migration to the cloud, and commercializing novel diagnostic biomarkers. Internationally, veterinary diagnostic testing frequency per pet in Europe, Japan, and Latin America is less than half the US level; IDEXX is rapidly deploying direct sales teams across international markets to capture extensive overseas testing adoption. In software, IDEXX is migrating clinics from legacy on-premise software to cloud-native ezyVet, which automates billing and integrates diagnostic orders seamlessly. In assay innovation, IDEXX is expanding early cancer screening and feline infectious disease test panels to detect illnesses years before clinical symptoms emerge.
How IDEXX Laboratories Makes Money
IDEXX operates a classic, highly profitable razor-and-blade business model centered on long-term veterinary clinic relationships. The company places in-clinic diagnostic instruments (chemistry, hematology, and urinalysis analyzers) in veterinary clinics under multi-year customer commitments (typically 6-year contracts). Once an analyzer is installed, the clinic must exclusively purchase IDEXX's proprietary, single-use test slides, reagent packs, and calibration cartridges for every diagnostic test run on a sick or wellness pet, generating recurring, high-margin consumable revenue. CAG Diagnostics Recurring Revenue (consumables, reference lab tests, and software subscriptions) accounts for over 90% of total company revenue. In veterinary software, IDEXX charges recurring monthly SaaS fees for cloud practice management platforms (ezyVet) and digital imaging storage.
IDEXX Laboratories Acquisitions FAQ
Does IDEXX Laboratories acquire other companies?
Yes, IDEXX Laboratories executes targeted acquisitions to integrate complementary technologies, expand intellectual property, and enter new market verticals.
What is IDEXX Laboratories's acquisition strategy?
IDEXX Laboratories focuses on bolt-on acquisitions that can be rapidly integrated into its core technology architecture and commercial distribution channels.
How does IDEXX Laboratories fund its acquisitions?
Acquisitions are typically funded through cash from operations, revolving credit facilities, and strategic equity considerations.
What was one of IDEXX Laboratories's notable acquisitions?
IDEXX Laboratories has acquired specialized technology assets that enhance its core platform capabilities and expand its addressable customer base.
How does IDEXX Laboratories handle post-merger integration?
By migrating acquired codebases into its unified cloud infrastructure and retaining key engineering talent within specialized innovation pods.
Are acquisitions a primary or secondary growth driver?
Inorganic growth is secondary to robust organic product development, serving as a tactical accelerator for specific strategic capabilities.
Explore IDEXX Laboratories
Core profile pages, founders and related research hubs for this company.